Safety, Immunogenicity, and Lot-To-Lot Consistency of Live Attenuated Varicella Vaccine in 1-3 Years Old Children: A Double-Blind, Randomized Phase III Trial

Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2018.1551701
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Safety and Immunogenicity of a Live Attenuated Mumps Vaccine

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2014English

A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2015English

Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus Naive Children

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2008English

The Safety and Immunogenicity of Two Novel Live Attenuated Monovalent (Serotype 2) Oral Poliovirus Vaccines in Healthy Adults: A Double-Blind, Single-Centre Phase 1 Study

The Lancet
Medicine
2019English

Efficacy of a Russian-Backbone Live Attenuated Influenza Vaccine Among Young Children in Bangladesh: A Randomised, Double-Blind, Placebo-Controlled Trial

The Lancet Global Health
Medicine
2016English

Immunogenicity and Safety of a 12-Valent Pneumococcal Conjugate Vaccine in Infants Aged 6 to 10 Weeks : A Randomized, Double Blind, Active-Controlled Trial

Clinical and Experimental Pediatrics
2019English

Safety and Immunogenicity of a Live-Attenuated Junin (Argentine Hemorrhagic Fever) Vaccine in Rhesus Macaques

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
1993English

Safety, Tolerability, and Pharmacokinetics of Adrenomedullin in Healthy Males: A Randomized, Double-Blind, Phase 1 Clinical Trial

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2020English

A Second Dose of a Measles-Mumps-Rubella Vaccine Administered to Healthy Four-To-Six-Year-Old Children: A Phase III, Observer-Blind, Randomized, Safety and Immunogenicity Study Comparing GSK MMR and MMR II With and Without DTaP-IPV and Varicella Vaccines Co-Administration

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy